Perrigo vitamin settlement
This article was originally published in The Tan Sheet
Executive Summary
Private labeler will record $20.1 mil. pre-tax gain in fiscal fourth quarter ending June 30 stemming from settlements in vitamin price-fixing litigation. Settlement proceeds, which were received May 17, will boost net income by approximately $12.9 mil. Perrigo recorded $7.8 mil. pre-tax gain in Q3 following similar settlements (1"The Tan Sheet" Feb. 18, 2002, p. 14)...
You may also be interested in...
Perrigo vitamin settlement
Private labeler will record $7.8 mil. pre-tax gain in third quarter ending March 31 stemming from settlement with unidentified defendants in vitamin price-fixing litigation. "Effect on net income will be approximately $5 mil.," firm says in Feb. 1 SEC filing. Case against remaining price-fixing defendants is proceeding, notes Allegan, Mich.-based firm, which previously reported vitamin litigation settlement payments of $995,000 and $4.2 mil. for FY 2001 and 2000, respectively...
There’s ‘No Silver Bullet’ For Making Medicines Packaging Sustainable
There’s no simple answer to the question of how to make medicines packaging sustainable, says international recycling consultancy and Veolia Group subsidiary Circpack. “Manufacturers need to assess what works best for them, and recyclers will do the same,” Circpack analyst and circular packaging expert Filipe Vieira de Castro tells HBW Insight in this exclusive Q&A. “The best thing we can all do is put effort into finding common ground between systems, which comes down to better understanding the complexities between them.”
Entries Begin To Roll In For 2024 Industry Awards
Entries have now begun rolling in for the Global Generics & Biosimilars Awards, which returns to Milan this October, Free to enter and attend, the ceremony recognizes the top achievements across the generics, biosimilars and value added medicines industries.